These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14559329)

  • 1. Pravastatin in hyperlipidemia secondary to HIV protease inhibitors without response to fenofibrate: a brief preliminary report.
    de Luis DA; Bachiller P; Aller R; Eiros Bouza J; Izaola O
    Nutrition; 2003 Oct; 19(10):903-4. PubMed ID: 14559329
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and tolerability of pravastatin for the treatment of HIV-1 protease inhibitor-associated hyperlipidaemia: a pilot study.
    Baldini F; Di Giambenedetto S; Cingolani A; Murri R; Ammassari A; De Luca A
    AIDS; 2000 Jul; 14(11):1660-2. PubMed ID: 10983656
    [No Abstract]   [Full Text] [Related]  

  • 3. Fenofibrate in hyperlipidaemia secondary to HIV protease inhibitors. Fenofibrate and HIV protease inhibitor.
    de Luis DA; Bachiller P; Aller R
    Nutrition; 2001 May; 17(5):414-5. PubMed ID: 11377136
    [No Abstract]   [Full Text] [Related]  

  • 4. Dyslipidemia in HIV-positive patients: a randomized, controlled, prospective study on ezetimibe+fenofibrate versus pravastatin monotherapy.
    Grandi AM; Nicolini E; Rizzi L; Caputo S; Annoni F; Cremona AM; Marchesi C; Guasti L; Maresca AM; Grossi P
    J Int AIDS Soc; 2014; 17(1):19004. PubMed ID: 25148829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperlipidemia related to the use of HIV-protease inhibitors: natural history and results of treatment with fenofibrate.
    Caramelli B; de Bernoche CY; Sartori AM; Sposito AC; Santos RD; Monachini MC; Strabelli T; Uip D
    Braz J Infect Dis; 2001 Dec; 5(6):332-8. PubMed ID: 11980596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reversibility of severe hyperlipemia secondary to indinavir with micronized phenofibrate].
    de Luis DA; Aller R; Rachiller P; Ignacio Tortosa J
    Med Clin (Barc); 1999 Nov; 113(18):716-7. PubMed ID: 10650577
    [No Abstract]   [Full Text] [Related]  

  • 7. Rosuvastatin versus pravastatin in dyslipidemic HIV-1-infected patients receiving protease inhibitors: a randomized trial.
    Aslangul E; Assoumou L; Bittar R; Valantin MA; Kalmykova O; Peytavin G; Fiévet MH; Boccara F; Bonnefont-Rousselot D; Melchior JC; Giral P; Costagliola D
    AIDS; 2010 Jan; 24(1):77-83. PubMed ID: 19838098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of protease inhibitor-associated hyperlipidemia.
    Penzak SR; Chuck SK
    Am J Cardiovasc Drugs; 2002; 2(2):91-106. PubMed ID: 14727985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV, HAART, and hyperlipidemia: balancing the effects.
    Sherer R
    J Acquir Immune Defic Syndr; 2003 Oct; 34 Suppl 2():S123-9. PubMed ID: 14703941
    [No Abstract]   [Full Text] [Related]  

  • 10. Statins in HIV-associated lipodystrophy and metabolic syndrome: is there a missing link?
    Gharakhanian S; Boccara F; Capeau J
    AIDS; 2006 Apr; 20(7):1061-3. PubMed ID: 16603860
    [No Abstract]   [Full Text] [Related]  

  • 11. Atorvastatin for protease inhibitor-related hyperlipidaemia.
    Murillas J; Martín T; Ramos A; Portero JL
    AIDS; 1999 Jul; 13(11):1424-5. PubMed ID: 10449305
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipid lowering therapy with fluvastatin and pravastatin in patients with HIV infection and antiretroviral therapy: comparison of efficacy and interaction with indinavir.
    Benesic A; Zilly M; Kluge F; Weissbrich B; Winzer R; Klinker H; Langmann P
    Infection; 2004 Aug; 32(4):229-33. PubMed ID: 15293079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-associated dyslipidaemia among HIV antibody-positive patients in Ireland: prevalence and management strategies.
    Nolan DP; O'Connor MB; O'Connor C; Moriarty M; O'Leary A; Bergin C
    Int J STD AIDS; 2010 Jan; 21(1):75-6. PubMed ID: 19884356
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of fluvastatin in hyperlipidemic protease inhibitor-treated HIV-infected patients.
    Doser N; Kübli S; Telenti A; Marzolini C; Chave JP; Feihl F; Buclin T; Pannatier A; Darioli R; Nicod P; Waeber B; Mooser V
    AIDS; 2002 Sep; 16(14):1982-3. PubMed ID: 12351967
    [No Abstract]   [Full Text] [Related]  

  • 15. [HIV-infection, HAART (highly-active antiretroviral therapy) and hyperlipidemia].
    Hirsch HH; Battegay M
    Dtsch Med Wochenschr; 2003 May; 128(19):1051-4. PubMed ID: 12736856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: a comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia.
    Saklamaz A; Comlekci A; Temiz A; Caliskan S; Ceylan C; Alacacioglu A; Yesil S
    Metabolism; 2005 May; 54(5):677-81. PubMed ID: 15877299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary advice with or without pravastatin for the management of hypercholesterolaemia associated with protease inhibitor therapy.
    Moyle GJ; Lloyd M; Reynolds B; Baldwin C; Mandalia S; Gazzard BG
    AIDS; 2001 Aug; 15(12):1503-8. PubMed ID: 11504982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhabdomyolysis after cerivastatin-gemfibrozil therapy in an HIV-infected patient with protease inhibitor-related hyperlipidemia.
    Mastroianni CM; d'Ettorre G; Forcina G; Lichtner M; Corpolongo A; Coletta S; Vullo V
    AIDS; 2001 Apr; 15(6):820-1. PubMed ID: 11371708
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term safety and efficacy of fenofibrate/pravastatin combination therapy in high risk patients with mixed hyperlipidemia not controlled by pravastatin monotherapy.
    Farnier M; Ducobu J; Bryniarski L
    Curr Med Res Opin; 2011 Nov; 27(11):2165-73. PubMed ID: 21973199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with pravastatin and fenofibrate improves atherogenic lipid profiles but not inflammatory markers in ACTG 5087.
    Fichtenbaum CJ; Yeh TM; Evans SR; Aberg JA
    J Clin Lipidol; 2010; 4(4):279-87. PubMed ID: 20824151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.